Enlivex Therapeutics Ltd. (ENLV)
NASDAQ: ENLV · Real-Time Price · USD
1.045
+0.015 (1.46%)
At close: Jun 18, 2025, 4:00 PM
1.060
+0.015 (1.44%)
After-hours: Jun 18, 2025, 6:10 PM EDT

Enlivex Therapeutics Market Cap

Enlivex Therapeutics has a market cap or net worth of $24.75 million as of June 18, 2025. Its market cap has decreased by -2.17% in one year.

Market Cap
24.75M
Enterprise Value
4.70M
1-Year Change
-2.17%
Ranking
Category
Stock Price
$1.05

Market Cap Chart

Created with Highcharts 11.4.8Range1 Month1M6 Months6MYear to DateYTD1 Year1Y3 Years3Y5 Years5Y10 Years10YFull HistoryMax31 Jul 201417 Jun 2025Max ▾20152016201720182019202020212022202320242025050M100M150M200M250M25M

Since July 31, 2014, Enlivex Therapeutics's market cap has decreased from $92.70M to $24.75M, a decrease of -73.30%. That is a compound annual growth rate of -11.42%.

History

DateMarket Cap% Change
Jun 17, 202524.60M-4.28%
Dec 31, 202425.70M-48.80%
Dec 29, 202350.20M-30.76%
Dec 30, 202272.50M-36.74%
Dec 31, 2021114.60M31.57%
Dec 31, 202087.10M2,388.57%
Dec 31, 20193.50M34.62%
Dec 31, 20182.60M-65.33%
Dec 29, 20177.50M-49.32%
Dec 30, 201614.80M-73.14%
Dec 31, 201555.10M-33.69%
Dec 31, 201483.10M-10.36%
View and export this data all the way back to 2014. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 704.75B
Johnson & Johnson 362.67B
Novo Nordisk 331.06B
AbbVie 327.65B
UnitedHealth Group 278.67B
Abbott Laboratories 230.37B
Novartis AG 227.75B
AstraZeneca 223.18B
Market Cap Rankings